Also listed on Novartis Consumer Healthcare S.A., an earlier holder on the record. The recorded assignments below show how it moved.
Term ends Apr 12, 2030 · High confidence
Held by Haleon CH SARL
Filed Mar 15, 2013 as application 29/449,733 · Granted Apr 12, 2016
Base term, 14 years from grant
Today
2016
2030
Clock starts
Apr 12, 2016
Apr 12, 2016
Term ends
Apr 12, 2030
Apr 12, 2030
base term
Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
None
Term adjustment
No prosecution delay on this record.
None
Terminal disclaimer
No disclaimer on this record.
14 years from grant
Base term
No maintenance fees are payable on this kind of patent.
This patent's term is its base term, 14 years from grant, with no adjustment for prosecution delay. No maintenance fees are payable on this kind of patent. Confidence: High. from the record
How we calculated this date
One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 14 years from grant | Granted Apr 12, 2016 | Apr 12, 2030 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | None on file | no change | High confidence |
| Terminal disclaimer cap | None on record | no cap applied | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Computed term end | The steps above, in order | Apr 12, 2030 | High confidence |
Assignments
Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Aug 25, 2015 Reel 36413, frame 396 | Hutchison, William; Munn, Caryl G | Novartis Consumer Health, Inc. | Assignment of Assignor's Interest |
| Aug 25, 2015 Reel 36413, frame 421 | Novartis Consumer Health, Inc. | Novartis AG | Assignment of Assignor's Interest |
| Jan 28, 2016 Reel 37604, frame 88 | Hutchison, William; Munn, Caryl G. | Novartis Consumer Health, Inc. | Assignment of Assignor's Interest |
| Jan 28, 2016 Reel 37604, frame 125 | Novartis Consumer Health, Inc. | Novartis AG | Assignment of Assignor's Interest |
| Feb 23, 2016 Reel 37795, frame 805 | Novartis AG | Novartis Consumer Healthcare S.A. | Assignment of Assignor's Interest |
| Jan 31, 2020 Reel 51889, frame 465 | Novartis Consumer Health S.A. | GSK Consumer Healthcare S.A. | Change of Name |
| Apr 13, 2022 Reel 59695, frame 58 | GSK Consumer Healthcare S.A. | GSK Consumer Healthcare SARL | Change of Legal Entity |
| Mar 1, 2024 Reel 66618, frame 404 | GSK Consumer Healthcare SARL | Haleon CH SARL | Change of Name |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center
No maintenance fees are payable on this kind of patent, so the record carries no fee events.
What's changing
Apr 2030
Term ends Apr 12, 2030. No maintenance fees are payable on this kind of patent
Citations
0
later US patents cite this one
That is below the median of design patents granted in 2016 in our data, the only group it is compared against.
How we rank
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
In force means the term is running and no lapse is on record. It is not a finding that the patent is valid.